Clinical Trial Update: Phase 2 Clinical Trial of Crizotinib for Children and Adults With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of crizotinib in children and adults with Neurofibromatosis type 2 and progressive vestibular schwannomas has completed and results have …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurofibromatosis Type
• Vestibular Schwannoma

Drugs mentioned

• Xalkori (crizotinib)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Neurofibromatosis 2, Progressive Vestibular Schwannoma (VS) | Phase 2 | Status: COMPLETED | Results posted: 2026-03-13